Is There Evidence for IGF1R-Stimulating Abs in Graves’ Orbitopathy Pathogenesis?

Is There Evidence for IGF1R-Stimulating Abs in Graves’ Orbitopathy Pathogenesis?

In this review, we summarize the evidence against direct stimulation of insulin-like growth factor 1 receptors (IGF1Rs) by autoantibodies in Graves’ orbitopathy (GO) pathogenesis. We describe a model of thyroid-stimulating hormone (TSH) receptor (TSHR)/IGF1R crosstalk and present evidence that obser...

Full description

Bibliographic Details
Main Authors:	Christine C. Krieger, Susanne Neumann, Marvin C. Gershengorn
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	International Journal of Molecular Sciences
Subjects:	IGF1R TSHR receptor crosstalk Graves’ orbitopathy IGF1R antibodies TSHR antibodies
Online Access:	https://www.mdpi.com/1422-0067/21/18/6561

Similar Items

Orbital Signaling in Graves’ Orbitopathy
by: Mohd Shazli Draman, et al.
Published: (2021-11-01)

ELF3-induced miR-182 inhibits adipogenic differentiation in Graves’ orbitopathy by targeting thyrotropin receptor
by: Sha Wang, et al.
Published: (2023-01-01)

TSHR169 Antigen Specifically Binds to the Thyroid-stimulating Autoantibody, Representing an Effective Biomarker for Graves’ Disease
by: Zulkarnain Zulkarnain, et al.
Published: (2019-03-01)

Gut microbiota in experimental murine model of Graves’ orbitopathy established in different environments may modulate clinical presentation of disease
by: Giulia Masetti, et al.
Published: (2018-05-01)

Comparison of orbital fibroblasts from Graves’ ophthalmopathy and healthy control
by: Yu Wu, et al.
Published: (2024-04-01)

Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves’ disease
by: Hidefumi Inaba, et al.
Published: (2016-08-01)

Characterizing the Interplay of Lymphocytes in Graves’ Disease
by: Mackenzie Hansen, et al.
Published: (2023-04-01)

Factors associated with severity of orbitopathy in patients with Graves' disease
by: Tauseef Nabi, et al.
Published: (2020-01-01)

Regulation of TSHR Expression in the Thyroid and Thymus May Contribute to TSHR Tolerance Failure in Graves' Disease Patients via Two Distinct Mechanisms
by: Ana Marín-Sánchez, et al.
Published: (2019-07-01)

Thyroid Receptor Antibody and the Development of Graves’ Orbitopathy: Clinical Experience of using Radioiodine Ablation in the Management of Graves’ Orbitopathy in post-iodine ablation hypothyroid patient
by: Edelyn Christina, et al.
Published: (2023-06-01)

Role of extrathyroidal TSHR expression in adipocyte differentiation and its association with obesity
by: Lu Sumei, et al.
Published: (2012-01-01)

Prognostic significance of thyroid-stimulating hormone receptor antibodies in moderate-to-severe graves’ orbitopathy
by: Jungyul Park, et al.
Published: (2023-05-01)

Steroid-resistant Graves' orbitopathy: Therapeutic options
by: Klet Sanja, et al.
Published: (2023-01-01)

Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy
by: Irene Campi, et al.
Published: (2022-01-01)

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis
by: Carla De Giovanni, et al.
Published: (2019-02-01)

Elevated serum concentrations of IGF-1 and IGF-1R in patients with thyroid cancers
by: Hanna Lawnicka, et al.
Published: (2020-03-01)

TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy
by: Mira Siderova, et al.

Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature
by: Neeraja Boddu, et al.
Published: (2017-07-01)

Mini Review: Molecular Interpretation of the IGF/IGF-1R Axis in Cancer Treatment and Stem Cells-Based Therapy in Regenerative Medicine
by: Syuan-Ling Lin, et al.
Published: (2022-10-01)

Therapeutic Targeting of the IGF Axis
by: Eliot Osher, et al.
Published: (2019-08-01)

Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy
by: Luigi Bartalena, et al.
Published: (2020-11-01)

Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
by: Stefanie de Groot, et al.
Published: (2020-11-01)

Adipocytokines in Graves’ orbitopathy and the effect of high-dose corticosteroids
by: Jan Schovanek, et al.
Published: (2021-01-01)

Puls-therapy with metilprednisolon in Grave's orbitopathy
Published: (2012-12-01)

Associations between Lipid Profiles and Graves’ Orbitopathy can Be HLA-Dependent
by: Magdalena Stasiak, et al.
Published: (2023-05-01)

Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
by: Dorota Walasik-Szemplińska, et al.
Published: (2019-12-01)

Brief Report - Monoclonal Antibodies Illustrate the Difficulties in Measuring Blocking TSH Receptor Antibodies
by: Terry F. Davies, et al.
Published: (2022-07-01)

Assessing the efficacy of various treatment regimens for patients with endocrine ophthalmopathy associated with Graves’ disease
by: Yu. V. Buldygina, et al.
Published: (2022-03-01)

Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis
by: Tülay Şimşek, et al.
Published: (2017-01-01)

A review of TSHR- and IGF-1R-related pathogenesis and treatment of Graves’ orbitopathy
by: Xuejiao Cui, et al.
Published: (2023-01-01)

Teprotumumab: a disease modifying treatment for graves’ orbitopathy
by: Michelle Ting, et al.
Published: (2020-07-01)

Insulin-like Growth Factor-1 (IGF-1) Related Drugs in Pain Management
by: Seokhyun Jin, et al.
Published: (2023-05-01)

The IGF/Insulin-IGFBP Axis in Corneal Development, Wound Healing, and Disease
by: Whitney L. Stuard, et al.
Published: (2020-03-01)

Rituximab in the treatment of Graves’ orbitopathy: latest updates and perspectives
by: Jakub Supronik, et al.
Published: (2022-11-01)

The IGF-1 Signaling Pathway in Viral Infections
by: Agata Józefiak, et al.
Published: (2021-07-01)

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
by: Yinqi Zhang, et al.
Published: (2021-11-01)

Update on the surgical management of Graves’ orbitopathy
by: Joonyoung Baeg, et al.
Published: (2023-02-01)

Current Knowledge on Graves’ Orbitopathy
by: Katarzyna Gontarz-Nowak, et al.
Published: (2020-12-01)

Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical Diagnostic and in Sports
by: Julian Bailes, et al.
Published: (2021-02-01)

Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
by: Jing Ding, et al.
Published: (2022-09-01)